MRMD(MRMD)
MRMD
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $161M | $170M | $171M |
| Low | $160M | $168M | $169M |
| High | $163M | $171M | $172M |
| EBITDA Avg | $21M | $22M | $22M |
| Low | $21M | $22M | $22M |
| High | $21M | $22M | $23M |
| EBIT Avg | $13M | $13M | $14M |
| Low | $13M | $13M | $13M |
| High | $13M | $14M | $14M |
| Net Income Avg | $-18M | $-10M | $-8M |
| Low | $-18M | $-10M | $-8M |
| High | $-17M | $-10M | $-8M |
| EPS Avg | $-0.04 | $-0.03 | $-0.02 |
| Low | $-0.05 | $-0.03 | $-0.02 |
| High | $-0.04 | $-0.02 | $-0.02 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $41M | $41M | $40M | $41M | $42M | $42M | $42M | $43M |
| Low | $41M | $41M | $39M | $41M | $42M | $42M | $41M | $42M |
| High | $41M | $41M | $40M | $41M | $42M | $42M | $42M | $43M |
| EBITDA Avg | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $6M |
| Low | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $6M |
| High | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $6M |
| EBIT Avg | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M |
| Low | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M |
| High | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M |
| Net Income Avg | $-2M | $-10M | — | — | — | — | — | — |
| Low | $-2M | $-10M | — | — | — | — | — | — |
| High | $-2M | $-10M | — | — | — | — | — | — |
| EPS Avg | $-0.01 | $-0.03 | — | — | — | — | — | — |
| Low | $-0.01 | $-0.03 | — | — | — | — | — | — |
| High | $-0.00 | $-0.02 | — | — | — | — | — | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — |